Medicare Multi-Cancer Early Detection Screening Coverage Act
A BILL
To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Sec. 2 Purpose
Sec. 3 Medicare coverage of multi-cancer early detection screening tests
“(KK) multi-cancer early detection screening tests (as defined in subsection (nnn));”
“(nnn) Multi-Cancer early detection screening tests—The term “multi-cancer early detection screening test” means any of the following tests, approved or cleared by the Food and Drug Administration, insofar as the Secretary determines coverage of such tests is appropriate, furnished to an individual for the purpose of earlier detection of cancer across many cancer types (such as described in the National Cancer Institute’s Annual Report to the Nation on the Status of Cancer):
“(1) A genomic sequencing blood or blood product test that includes the analysis of cell-free nucleic acids.
“(2) Such other equivalent tests (which are based on blood, blood products, urine, or other sample of biological material) as the Secretary determines appropriate in providing results comparable to those obtained with a test described in paragraph (1).”
“(10) No payment may be made under this part for a multi-cancer early detection screening test (as defined in section 1861(nnn)) for an individual if such a test was furnished to the individual during the previous 11 months.”
“(Q) in the case of a multi-cancer early detection screening test (as defined in section 1861(nnn)), which is performed more frequently than is covered under section 1833(h)(10);”